Potential mechanisms of reduced heart failure hospitalization with SGLT2 inhibitors Four main potential reasons for protection against heart failure (HF) hospitalization by SGLT2 inhibitors: Contraction of plasma volume
Cardiology MCQ – Least progression of valvular lesion Which of these three lesions is least likely to progressive and have a favourable clinical course among aortic stenosis, mitral
Cardiology MCQ – Treatment of transthyretin amyloid cardiomyopathy – Answer Recently developed pharmacotherapy which has been shown to halt and reverse the progression of transthyretin amyloid cardiomyopathy: Correct
CHAD-STOP for cardiac amyloidosis CHAD-STOP is the mnemonic for the initial steps in the management of cardiac amyloidosis: C: Conduction and rhythm disorder prevention H: High heart rate
Cardiology MCQ – Treatment of transthyretin amyloid cardiomyopathy Recently developed pharmacotherapy which has been shown to halt and reverse the progression of transthyretin amyloid cardiomyopathy: Trastuzumab Tafamidis Tranexamic
Risk factors for non response with CRT About one third of patients who receive a cardiac resynchronization therapy (CRT) do not respond well to the device therapy. Some
Cardiology MCQ – Associations of primary aldosteronism – Answer Which of the following are associated with primary aldosteronism? Correct answer 4. All of the above Primary aldosteronism is
Cardiology MCQ – Primary aldosteronism – Answer Primary aldosteronism is an important cause of secondary hypertension. It is characterised by: Correct answer: 1. Low levels of plasma renin
“Exclusion tests” for primary aldosteronism Oral sodium loading test Saline infusion test Captopril challenge test Fludrocortisone with salt loading test Though these tests were proposed as ‘confirmatory tests’
